Manufacturing site not PQ-ready during dossier submission – PQ assessment risk and mitigation


Published on 29/01/2026

Navigating PQ Readiness Challenges in Pharmaceutical Manufacturing

Manufacturers often face risks when their production sites are not fully ready for PQ assessments during dossier submissions. This situation can significantly impact product approval and market entry, requiring immediate attention and corrective actions. In this playbook, we will outline actionable strategies to triage the problem, analyze its root causes, implement corrective actions, and ensure robust compliance with GMP standards.

For a broader overview and preventive tips, explore our WHO Prequalification (PQ).

By the end of this article, you will have a clear roadmap to identify potential issues, instigate investigations, and fortify your quality systems to ensure your manufacturing site meets PQ readiness expectations of regulatory bodies such as the FDA, EMA, and WHO.

Symptoms/Signals on the Floor or in the Lab

Identifying the symptoms or signals of unpreparedness can prevent further complications throughout the production process. Key indications may include:

  • Inconsistent Batch Quality: Unexpected deviations in batch characteristics or
performance.
  • Frequent Deviations: An uptick in deviation reports related to processes or equipment failures.
  • Outdated Documentation: Missing or poorly maintained quality records and validation documentation.
  • Staff Competency Issues: Inadequate training logs and qualifications for personnel involved in critical processes.
  • Lack of Compliance Training: Insufficient awareness of GMP requirements and how they apply to daily tasks.
  • Likely Causes

    Understanding the underlying causes of unpreparedness is critical. Generally, these can be categorized based on the 5 M’s: Materials, Method, Machine, Man, Measurement, and Environment.

    1. Materials

    • Quality of raw materials not compliant with specifications.
    • Incorrect storage conditions leading to degradation.

    2. Method

    • Inadequate validation of manufacturing processes and analytical methods.
    • Outdated SOPs not reflecting current practices.

    3. Machine

    • Equipment not calibrated or maintained as per schedule.
    • Failure to implement automated tracking systems for processes.

    4. Man

    • Improper training of personnel leading to errors in production.
    • Poor communication between departments affecting workflow.

    5. Measurement

    • Inaccurate data collected compromising quality assessments.
    • Insufficient monitoring systems not capturing critical process variances.

    6. Environment

    • Non-compliance with controlled environmental conditions.
    • Inadequate cleaning and sanitation procedures.

    Immediate Containment Actions (first 60 minutes)

    Taking swift action is essential in the first hour following the identification of potential PQ readiness issues. The containment strategy should include:

    • Stop Production: Cease ongoing processes if any immediate risks have been identified.
    • Isolate Affected Batches: Segregate impacted products to mitigate contamination or further deviations.
    • Document Initial Observations: Capture all observed symptoms and immediate actions taken.
    • Notify Key Personnel: Inform QA, production, and senior management of the situation.
    • Prepare a Rapid Assessment Team: Assemble cross-functional team members to address the problem.

    Investigation Workflow

    Once containment actions are in place, initiate a structured investigation workflow to identify the root of the problem:

    1. Data Collection

    • Review batch records, quality control results, and production logs.
    • Gather information from personnel involved in affected processes.
    • Maintain records of environmental monitoring logs where applicable.

    2. Data Interpretation

    • Conduct trend analysis on quality control data to identify any patterns.
    • Evaluate process capabilities and any deviations to gauge impact.

    Root Cause Tools

    Utilizing effective root cause analysis (RCA) tools is crucial in understanding underlying issues:

    Tool Application
    5 Whys Useful for straightforward issues where the problem can be resolved by drilling down into ‘why’ it happened.
    Fishbone Diagram Effective for complex problems with multiple contributing factors, allowing visual representation of causes.
    Fault Tree Analysis Applicable for systematic identification of failure paths, especially in equipment or method-related issues.

    CAPA Strategy

    A well-defined Corrective and Preventive Action (CAPA) strategy is fundamental in addressing and preventing issues:

    1. Correction

    • Immediately correct the failure, ensuring compliance with specifications.
    • Implement interim procedures or temporary fixes, if necessary.

    2. Corrective Action

    • Identify and resolve root causes that led to the initial failure.
    • Revise processes, equipment calibration routines, or training programs as needed.

    3. Preventive Action

    • Establish controls to mitigate the risk of recurrence.
    • Train staff on updated procedures and implications of non-compliance.

    Control Strategy & Monitoring

    A robust control strategy for monitoring PQ readiness includes:

    • Statistical Process Control (SPC): Implement SPC to track process stability and capability.
    • Sampling Plans: Define acceptable limits for sampling batches ensuring consistent quality.
    • Alarm Systems: Utilize real-time alerts for critical operations to preemptively address deviations.
    • Verification Activities: Schedule routine checks of processes and equipment against established standards.

    Validation / Re-qualification / Change Control Impact

    Assess if validation processes need to be enacted after addressing identified issues:

    Related Reads

    • Re-validation: Conduct re-validation of processes impacted by the effectiveness of corrective actions.
    • Change Control: Manage any significant alterations to processes or systems via formal change control mechanisms.
    • Documentation: Ensure all amendments are captured in a transparent manner to facilitate future audits.

    Inspection Readiness: What Evidence to Show

    Preparing for inspections requires meticulous documentation to ensure compliance with GMP standards:

    • Batch Documentation: Ensure that batch records, including variations and corrective measures taken, are complete and accessible.
    • Deviation Records: Document all deviations and CAPA actions taken in response to these events.
    • Audit Logs: Maintain clear logs of internal and external audits conducted, alongside results and follow-up actions implemented.
    • Training Records: Keep comprehensive training logs showcasing personnel qualifications for their roles and responsibilities.

    FAQs

    What is PQ readiness?

    PQ readiness refers to a manufacturing site’s compliance with applicable quality standards and processes required prior to submission of a dossier for prequalification review.

    What are the key regulatory bodies concerned with PQ?

    The primary bodies include WHO, FDA, EMA, and MHRA, which set guidelines for ensuring that pharmaceutical companies meet quality benchmarks.

    How critical is CAPA in maintaining PQ readiness?

    CAPA is crucial as it addresses not only the immediate issues but also identifies opportunities to prevent future non-compliances through corrective and preventive actions.

    What types of data should be prioritized in investigations?

    Focus on batch records, employee training logs, process monitoring data, and any deviations from standard operating procedures.

    How often should re-validation be carried out?

    Re-validation should occur whenever there are significant changes in processes, equipment, or if deviations impact quality.

    What are common challenges faced during audits?

    Challenges may include insufficient documentation, lack of employee training records, and unaddressed deviations or non-conformances.

    What role does statistical process control (SPC) play?

    SPC serves as a proactive measure to monitor process behavior and maintain consistency in product quality over time.

    What should be included in change control management?

    Change control management should encompass a detailed assessment of the proposed change, potential impacts on quality, and the documentation of the change process.

    Why is it important to have a cross-functional team for investigations?

    A cross-functional team brings diverse perspectives and expertise necessary to thoroughly evaluate issues and implement effective resolutions swiftly.

    How can we ensure long-term compliance post-issue resolution?

    Regularly update SOPs, conduct ongoing training, and establish a culture of quality within the organization to promote ongoing compliance.

    Pharma Tip:  Deviation history questioned during inspection preparation – how to defend manufacturing readiness